Global Veterinary Vaccines Industry (2020 to 2025) - Technological Advancements Present Lucrative Opportunities - ResearchAndMarkets.com

DUBLIN--()--The "Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global veterinary vaccines market is projected to reach USD 11,337.5 million by 2025 from USD 8,014.2 million in 2020, at a CAGR of 7.2% from 2020 to 2025.

The growth of this market is driven majorly by factors such as the initiatives by various government agencies and animal associations to maintain animal health, rising incidence of zoonotic diseases, growth in the companion animal population, and the rising demand for animal-derived food products are driving the growth of this market. On the other hand, the high storage cost of vaccines is restraining market growth.

By technology, the recombinant vaccines segment is expected to grow at the highest CAGR during the forecast period.

Based on technology, the veterinary vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The recombinant vaccine segment is expected to register the highest growth during the forecast period. This growth in this segment is driven advantages offered by recombinant vaccines such as the lack of need for adjuvants, free from pathogen contamination, exhibit no post-vaccination reactions, and provide higher safety.

By type, the porcine vaccines segment dominated the veterinary vaccines market in 2019.

Based on type, the veterinary vaccines market is segmented porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other animal vaccines. Porcine vaccines accounted for the largest share of the veterinary vaccines market in 2019, primarily due to the increasing porcine population, growing awareness about animal vaccination, and an outbreak of porcine diseases such as PRRS, swine influenza, and Aujeszky's Disease.

Asia Pacific veterinary vaccines market is expected to witness the highest growth during the forecast period.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.

Market Dynamics

Drivers

  • Growth in the Companion Animal Population
  • Rising Incidence of Zoonotic Diseases
  • Initiatives by Various Government Agencies and Animal Associations
  • Rising Demand for Animal-Derived Food Products

Restraints

  • High Storage Cost of Vaccines

Opportunities

  • Technological Advancements

Challenges

  • Inadequate Surveillance and Reporting Systems

Companies Profiled

  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco
  • Ceva
  • Virbac
  • Vetoquinol
  • Phibro Animal Health
  • Hester Biosciences
  • Hipra
  • Biogenesis Bago
  • Tianjin Ringpu
  • China Animal Husbandry
  • Jinyu Bio-Technology
  • Endovac Animal Health
  • Brilliant Bio Pharma Private Limited
  • Aptimmune Biologics
  • Indian Immunologicals Ltd.
  • Torigen
  • Verovaccines

For more information about this report visit https://www.researchandmarkets.com/r/n1wl42

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900